MarketsandMarkets

Pharmaceutical Grade Lithium Carbonate Market Report 2028: Unveiling Size, Share, and Industry Growth Dynamics

The major players operating in the pharmaceutical grade lithium carbonate market include Livent Corporation (US), Albemarle Corporation (US), Jiangsu Lianhuan Pharmaceutical Co., Ltd. (China), American Elements (US), Globe Química (US), Jiangsu Nhwa Pharmaceutical Co., Ltd. (China), Panchsheel Organics Ltd (POLTD) (India), Blanver (Brazil), and others.

 

The report "Pharmaceutical Grade Lithium Carbonate Market by Application (Extended Release, Immediate Release), Purity (99%, Above 99%), and Region (Asia Pacific, Europe, North America, Middle East & Africa, and South America) - Global Forecast to 2028", is projected to grow from USD 141 million in 2023 to USD 166 million by 2028, at a CAGR of 3.3% from 2023 to 2028. As the understanding of mental health conditions like bipolar disorder improves and more accurate diagnostic tools become available, there is expected to be an increased demand for medicines having pharmaceutical grade lithium carbonate that are used to manage these conditions.

Browse in-depth TOC on "Pharmaceutical Grade Lithium Carbonate Market"
170 market data Tables
42 Figures
150 Pages

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=146574055

By application, extended releasesegment is estimated to account for the largest market share in 2023.
Certain mental health disorders can experience fluctuations in symptoms when the drug concentration in the body varies. Extended release medications help to smooth out these fluctuations and provide a more constant effect. Also, extended release formulations can be preferred by healthcare providers because they offer a more controlled and predictable drug release profile, making it easier to tailor treatment plans to individual patient needs. All these factors are expected to enhance the demand for extended release pharmaceutical grade lithium carbonate medicines during the forecast period.

North America was the largest region in the pharmaceutical grade lithium carbonate market in 2022, by value.
The development of technology and innovation across several industries are characteristics of North America. Manufacturers of pharmaceutical grade lithium carbonates in the region make huge investment in the research & development to improve the performance qualities of medicines. The pharmaceutical grade lithium carbonate market in North America is expanding as a result of technological developments in pharmaceutical sector and awareness regarding mental health among people. Awareness campaigns and patient advocacy groups focusing on mental health conditions is contributing to enhance the understanding and acceptance of treatment options related to mental illness. This is expected to drive the market for pharmaceutical grade lithium carbonate in the country.s

Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=146574055

The major players operating in the pharmaceutical grade lithium carbonate market include Livent Corporation (US), Albemarle Corporation (US), Jiangsu Lianhuan Pharmaceutical Co., Ltd. (China), American Elements (US), Globe Química (US), Jiangsu Nhwa Pharmaceutical Co., Ltd. (China), Panchsheel Organics Ltd (POLTD) (India), Blanver (Brazil), and others.

About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com